Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop.
Fahn
S
S
The Neurological Institute, Columbia University, New York, NY, USA.
Clarence-Smith
K E
KE
Chase
T N
TN
D006801:Humans; D009410:Nerve Degeneration / Q000188:drug therapy / Q000503:physiopathology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D012106:Research; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology
D018696:Neuroprotective Agents; D011954:Receptors, Dopamine